![]()
|
|
||||||||
J. Biol. Chem., Vol. 276, Issue 19, 15571-15574, May 11, 2001
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Departments of The ribonucleoprotein telomerase
holoenzyme is minimally composed of a catalytic subunit, hTERT, and its
associated template RNA component, hTR. We have previously found two
additional components of the telomerase holoenzyme, the chaperones p23
and heat shock protein (hsp) 90, both of which are required for
efficient telomerase assembly in vitro and in
vivo. Both hsp90 and p23 bind specifically to hTERT and influence
its proper assembly with the template RNA, hTR. We report here that the
hsp70 chaperone also associates with hTERT in the absence of hTR and
dissociates when telomerase is folded into its active state, similar to
what occurs with other chaperone targets. Our data also indicate that
hsp90 and p23 remain associated with functional telomerase complexes,
which differs from other hsp90-folded enzymes that require only a
transient hsp90·p23 binding. Our data suggest that components of the
hsp90 chaperone complex, while required for telomerase assembly, remain associated with active enzyme, which may ultimately provide critical insight into the biochemical properties of telomerase assembly.
ACCELERATED PUBLICATION
Stable Association of hsp90 and p23, but Not hsp70, with Active
Human Telomerase*
,
,
,
, and
§¶
Pathology and
§ Human Genetics, Massey Cancer Center, Medical College of
Virginia at Virginia Commonwealth University, Richmond, Virginia
23298-0662
*
This work was supported by the V foundation (to S. E. H.),
the Mary Kay Ash Foundation (to S. E. H.), and the Howard Hughes Medical Institute (to J. L. J.).The costs of publication of this article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
This article has been cited by other articles:
![]() |
L. W. Elmore, M. W. Norris, S. Sircar, A. T. Bright, P. A. McChesney, R. N. Winn, and S. E. Holt Upregulation of Telomerase Function During Tissue Regeneration Experimental Biology and Medicine, August 1, 2008; 233(8): 958 - 967. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Niu, D. T. M. Leung, C. H. Ma, E. C. Y. Law, F. C. H. Tam, and P.-L. Lim Cells That Produce Deleterious Autoreactive Antibodies Are Vulnerable to Suicide J. Immunol., August 1, 2008; 181(3): 2246 - 2257. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Agarwal, S. Pandita, C. R. Hunt, A. Gupta, X. Yue, S. Khan, R. K. Pandita, D. Pratt, J. W. Shay, J.-S. A. Taylor, et al. Inhibition of Telomerase Activity Enhances Hyperthermia-Mediated Radiosensitization Cancer Res., May 1, 2008; 68(9): 3370 - 3378. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. A. Toogun, D. C. DeZwaan, and B. C. Freeman The Hsp90 Molecular Chaperone Modulates Multiple Telomerase Activities Mol. Cell. Biol., January 1, 2008; 28(1): 457 - 467. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Stahl, M. Retzlaff, M. Nassal, and J. Beck Chaperone activation of the hepadnaviral reverse transcriptase for template RNA binding is established by the Hsp70 and stimulated by the Hsp90 system Nucleic Acids Res., September 25, 2007; 35(18): 6124 - 6136. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Mizuno, S. Khurts, T. Seki, Y. Hirota, S. Kaneko, and S. Murakami Human Telomerase Exists in Two Distinct Active Complexes In Vivo J. Biochem., May 1, 2007; 141(5): 641 - 652. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. A. Toogun, W. Zeiger, and B. C. Freeman The p23 molecular chaperone promotes functional telomerase complexes through DNA dissociation PNAS, April 3, 2007; 104(14): 5765 - 5770. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Bagatell, L. Gore, M. J. Egorin, R. Ho, G. Heller, N. Boucher, E. G. Zuhowski, J. A. Whitlock, S. P. Hunger, A. Narendran, et al. Phase I Pharmacokinetic and Pharmacodynamic Study of 17-N-Allylamino-17-Demethoxygeldanamycin in Pediatric Patients with Recurrent or Refractory Solid Tumors: A Pediatric Oncology Experimental Therapeutics Investigators Consortium Study Clin. Cancer Res., March 15, 2007; 13(6): 1783 - 1788. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. R. Keppler, A. T. Grady, and M. B. Jarstfer The Biochemical Role of the Heat Shock Protein 90 Chaperone Complex in Establishing Human Telomerase Activity J. Biol. Chem., July 21, 2006; 281(29): 19840 - 19848. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Lee, N. Sengupta, A. Villagra, N. Rezai-Zadeh, and E. Seto Histone Deacetylase 8 Safeguards the Human Ever-Shorter Telomeres 1B (hEST1B) Protein from Ubiquitin-Mediated Degradation. Mol. Cell. Biol., July 1, 2006; 26(14): 5259 - 5269. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-L. Wu, C. Dudognon, E. Nguyen, J. Hillion, F. Pendino, I. Tarkanyi, J. Aradi, M. Lanotte, J.-H. Tong, G.-Q. Chen, et al. Immunodetection of human telomerase reverse-transcriptase (hTERT) re-appraised: nucleolin and telomerase cross paths J. Cell Sci., July 1, 2006; 119(13): 2797 - 2806. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Compton, L. W. Elmore, K. Haydu, C. K. Jackson-Cook, and S. E. Holt Induction of Nitric Oxide Synthase-Dependent Telomere Shortening after Functional Inhibition of Hsp90 in Human Tumor Cells Mol. Cell. Biol., February 15, 2006; 26(4): 1452 - 1462. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Banerji, M. Walton, F. Raynaud, R. Grimshaw, L. Kelland, M. Valenti, I. Judson, and P. Workman Pharmacokinetic-Pharmacodynamic Relationships for the Heat Shock Protein 90 Molecular Chaperone Inhibitor 17-Allylamino, 17-Demethoxygeldanamycin in Human Ovarian Cancer Xenograft Models Clin. Cancer Res., October 1, 2005; 11(19): 7023 - 7032. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Banerji, A. O'Donnell, M. Scurr, S. Pacey, S. Stapleton, Y. Asad, L. Simmons, A. Maloney, F. Raynaud, M. Campbell, et al. Phase I Pharmacokinetic and Pharmacodynamic Study of 17-Allylamino, 17-Demethoxygeldanamycin in Patients With Advanced Malignancies J. Clin. Oncol., June 20, 2005; 23(18): 4152 - 4161. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kawauchi, K. Ihjima, and O. Yamada IL-2 Increases Human Telomerase Reverse Transcriptase Activity Transcriptionally and Posttranslationally through Phosphatidylinositol 3'-Kinase/Akt, Heat Shock Protein 90, and Mammalian Target of Rapamycin in Transformed NK Cells J. Immunol., May 1, 2005; 174(9): 5261 - 5269. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Kim, S.-M. Park, M. R. Kang, S.-Y. Oh, T. H. Lee, M. T. Muller, and I. K. Chung Ubiquitin ligase MKRN1 modulates telomere length homeostasis through a proteolysis of hTERT Genes & Dev., April 1, 2005; 19(7): 776 - 781. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Khurts, K. Masutomi, L. Delgermaa, K. Arai, N. Oishi, H. Mizuno, N. Hayashi, W. C. Hahn, and S. Murakami Nucleolin Interacts with Telomerase J. Biol. Chem., December 3, 2004; 279(49): 51508 - 51515. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. AIGNER and T. R. CECH The Euplotes telomerase subunit p43 stimulates enzymatic activity and processivity in vitro RNA, July 1, 2004; 10(7): 1108 - 1118. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-C. Teng, Y.-Y. Chen, Y.-N. Su, P.-C. Chou, Y.-C. Chiang, S.-F. Tseng, and K.-J. Wu Direct Activation of HSP90A Transcription by c-Myc Contributes to c-Myc-induced Transformation J. Biol. Chem., April 9, 2004; 279(15): 14649 - 14655. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. M. Longshaw, J. P. Chapple, M. S. Balda, M. E. Cheetham, and G. L. Blatch Nuclear translocation of the Hsp70/Hsp90 organizing protein mSTI1 is regulated by cell cycle kinases J. Cell Sci., March 1, 2004; 117(5): 701 - 710. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. R. Hunt, D. J. Dix, G. G. Sharma, R. K. Pandita, A. Gupta, M. Funk, and T. K. Pandita Genomic Instability and Enhanced Radiosensitivity in Hsp70.1- and Hsp70.3-Deficient Mice Mol. Cell. Biol., January 15, 2004; 24(2): 899 - 911. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Beck and M. Nassal Efficient Hsp90-independent in Vitro Activation by Hsc70 and Hsp40 of Duck Hepatitis B Virus Reverse Transcriptase, an Assumed Hsp90 Client Protein J. Biol. Chem., September 19, 2003; 278(38): 36128 - 36138. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Oxelmark, R. Knoblauch, S. Arnal, L. F. Su, M. Schapira, and M. J. Garabedian Genetic Dissection of p23, an Hsp90 Cochaperone, Reveals a Distinct Surface Involved in Estrogen Receptor Signaling J. Biol. Chem., September 19, 2003; 278(38): 36547 - 36555. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Villa, M. Folini, C. D. Porta, A. Valentini, M. Pennati, M. G. Daidone, and N. Zaffaroni Inhibition of telomerase activity by geldanamycin and 17-allylamino, 17-demethoxygeldanamycin in human melanoma cells Carcinogenesis, May 1, 2003; 24(5): 851 - 859. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-S. Cong, W. E. Wright, and J. W. Shay Human Telomerase and Its Regulation Microbiol. Mol. Biol. Rev., September 1, 2002; 66(3): 407 - 425. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-L. Mergny, J.-F. Riou, P. Mailliet, M.-P. Teulade-Fichou, and E. Gilson Natural and pharmacological regulation of telomerase Nucleic Acids Res., February 15, 2002; 30(4): 839 - 865. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. L. Beattie, W. Zhou, M. O. Robinson, and L. Harrington Functional Multimerization of the Human Telomerase Reverse Transcriptase Mol. Cell. Biol., September 15, 2001; 21(18): 6151 - 6160. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Akalin, L. W. Elmore, H. L. Forsythe, B. A. Amaker, E. D. McCollum, P. S. Nelson, J. L. Ware, and S. E. Holt A Novel Mechanism for Chaperone-mediated Telomerase Regulation during Prostate Cancer Progression Cancer Res., June 1, 2001; 61(12): 4791 - 4796. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |